1. Anticancer exffect of 9-nitrocamptothecin liposome aerosol on human cancer xenografts in nude mice

   • Vernon Knight
   • Nadezhda V. Koshkina
   • Brain E. Gilbert

   ORIGINAL ARTICLE Pages: 177 - 186

2. Distribution of camptothecin after delivery as a liposome aerosol or following intramuscular injection in mice

   • Nadezhda V. Koshkina
   • Brain E. Gilbert
   • Vernon Knight

   ORIGINAL ARTICLE Pages: 187 - 192

3. Cisplatin efflux, binding and intracellular pH in the HTB56 human lung adenocarcinoma cell line and the E-8/0.7 cisplatin-resistant variant

   • Quincy Chau
   • David J. Stewart

   ORIGINAL ARTICLE Pages: 193 - 202

4. Vincristine pharmacokinetics after repetitive dosing in children

   • C. E. M. Gidding
   • G. J. Meeuwsen-de Boer
   • S. S. N. de Graaf

   ORIGINAL ARTICLE Pages: 203 - 209

5. Phase II study of a radiotherapy/etoposide combination for patients with newly malignant gliomas

   • P. Beauchesne
   • C. Soler
   • J. Brunon

   ORIGINAL ARTICLE Pages: 210 - 216

6. Failure of taxol-based combination chemotherapy for malignant glioma cannot be overcome by G2/M checkpoint abrogators or altering the p53 status

   • Raoul Borbé
   • Johannes Rieger
   • Michael Weller

   ORIGINAL ARTICLE Pages: 217 - 227

7. Phase I/pharmacokinetic trial of the novel thioxanthone SR233377 (WIN33377) on a 5-day schedule

   • James P. Stevenson
   • Deborah DeMaria
   • Peter J. O'Dwyer

   ORIGINAL ARTICLE Pages: 228 - 234

8. Characterization of MGI 114 (HMAF) histiospecific toxicity in human tumor cell lines

   • Michael J. Kelner
   • Trevor C. McMorris
   • Raymond Taetle

   ORIGINAL ARTICLE Pages: 235 - 240

9. Cremophor reduces paclitaxel penetration into bladder wall during intravesical treatment

   • Ian Knemeyer
   • M. Guillaume Wientjes
   • Jessie L.-S. Au

   ORIGINAL ARTICLE Pages: 241 - 248

10. Enhancement of cisplatin cytotoxicity by terbium in cisplatin-resistant MDA/CH human breast cancer cells

    • Teresa L. Fuller
    • Robert G. Canada

    ORIGINAL ARTICLE Pages: 249 - 252

11. A phase II study of the effectiveness of docetaxel (Taxotere) in women with advanced breast cancer previously treated with polychemotherapy

    • C. G. Alexopoulos
    • G. Rigatos
    • for the Hellenic Cooperative Interhospital Group in Oncology (He-CIGO)

    ORIGINAL ARTICLE Pages: 253 - 258

12. A phase II/pharmacokinetic trial of high-dose progesterone in combination with paclitaxel

    • S. Aebi
    • T. W. Schnider
    • R. D. Christen

    ORIGINAL ARTICLE Pages: 259 - 265